Venus Remedies Ltd.

₹457.3

Venus Remedies Ltd.

  • NSE : VENUSREM

₹457.3

₹457.3

11.6 (2.6%) - 14 Jun 2025 04:20 PM
  • NSE : VENUSREM

About Company

Venus Remedies Limited is a research and innovation-driven Indian pharmaceutical company with a global footprint in many nations. The company has several manufacturing facilities, hundreds of market authorisations, many global patents and product basket. Its GLP-accredited Venus Medicine Research Centre (VMRC) is committed to offering the world novel breakthroughs catering to the critical care and super specialty segments. Its manufacturing facilities deliver world-class products accepted by regulators in advanced and developing pharmaceutical markets.

Market Cap. ₹ 611 Cr.
52 Week - High/Low ₹ 477/270
P/E Ratio 11.63
P/B Ratio 1.20
Enterprise Value ₹ 574 Cr.
ROE % 6.18
RSI Value -
EMA 50 371.34
EMA 200 334.76
Market Cap. ₹ 611 Cr.
52 Week - High/Low ₹ 477/270
P/E Ratio 13.49
P/B Ratio 1.25
Enterprise Value ₹ 572 Cr.
ROE % 6.01
RSI Value -
EMA 50 371.34
EMA 200 334.76

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.